Cardlytics (CDLX) Tops Q1 EPS by 27c
Cardlytics (NASDAQ: CDLX) reported Q1 EPS of ($0.35), $0.27 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $32.7 million versus the consensus estimate of $29.81 million.
For earnings history and earnings-related data on Cardlytics (CDLX) click here.
